Glucagon-like peptide-1 receptor agonists such as semaglutide are synthetic analogues to GLP-1 which is an incretin hormone secreted upon food ingestion and is primarily involved in regulation of blood glucose levels and satiety in response to a carbohydrate load
This effect helps people stick to healthier eating patterns without feeling constantly deprived
This suggests stopping GLP-1 drugs allows stomach function to return as medication clears over four to five weeks
This information does not endorse any medicine as safe, effective, or approved for treating any patient or health condition
Subcutaneous injection into abdominal fat, using 29-31 gauge insulin syringes, provides reliable delivery with minimal discomfort
Patients were excluded if they had K-L grades of 0 or 4, diabetic vascular disease, secondary OA or a history of diabetic foot or knee surgery